Kontafarma China Holdings Limited (HKG:1312)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0280
0.00 (0.00%)
At close: Mar 10, 2026

Kontafarma China Holdings Company Description

Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.

It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities.

It also offers corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022.

The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.

Kontafarma China Holdings Limited
Country Cayman Islands
Founded 2011
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 655
CEO Feifei Wang

Contact Details

Address:
Sun Hung Kai Centre
Wan Chai
Hong Kong
Phone 852 2731 6500
Website kontafarma.com.hk

Stock Details

Ticker Symbol 1312
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency HKD
ISIN Number KYG8918D1088
SIC Code 3241

Key Executives

Name Position
Feifei Wang Executive Chairman and President
Zixiu Guo Financial Controller and Executive Director
Jiankun Liu Executive Director
Jie Zhang Chief Operating Officer
Lok Tung Chan Company Secretary